Bristol-Myers could spend $2.2B in deal with Dutch biotech

April 6, 2015 4:03 PM

60 0

Drugmaker Bristol-Myers Squibb said Monday it will work with Dutch biotechnology company uniQure to develop gene therapies for cardiovascular diseases.

The companies will focus first on a treatment for congestive heart failure. They said uniQure could get more than $2.2 billion from the deal in total, and Bristol-Myers Squibb will also take a minority stake in the company.

Also watch: Raiders' Derek Carr signs new five-year deal worth $125 million

Read more

To category page